WASHINGTON (dpa-AFX) - StemCells, Inc. (STEM) reported fourth-quarter net loss of $7.2 million or $0.47 per share, narrower than the prior year's net loss of $9.0 million or $0.70 per share.
On average, 3 analysts polled by Thomson Reuters expected the company to report a loss of $0.36 per share for the quarter. Analysts' estimates typically exclude one-time items.
Total revenues for the quarter declined 23 percent to $541,000 from $699,000 million last year, due to lower product sales and lower licensing and grant revenues.
Analysts expected revenues of $490,000 for the quarter.
Copyright RTT News/dpa-AFX
© 2012 AFX News
